A recent systematic review and meta-analysis examined the impact of surgical timing in patients with hip fractures receiving direct oral anticoagulants (DOACs). With DOAC use increasingly common, concerns about perioperative bleeding can contribute to delays in hip fracture surgery.

The review included six cohort studies involving 1,575 patients, comparing surgery performed within 24 hours of the last DOAC dose with surgery performed between 24 and 48 hours.

Key Findings

The findings suggest that, in appropriately selected patients, DOAC use alone may not justify routinely delaying hip fracture surgery. However, the evidence remains limited by the observational design of the included studies, potential confounding, and risk of bias. Further high-quality research is needed to establish the optimal timing of surgery in patients receiving DOAC therapy. The authors ultimately conclude that early surgery within 24 hours of the last DOAC dose can be supported in appropriately selected patients.

Read the article here.

We are pleased to invite you to attend the upcoming Annual FFN General Assembly 2026. 

Date: Monday 12 October 2026

Time: 14.00 CEST

Virtual via Zoom

The General Assembly is a vital opportunity for all FFN members to hear
about the organization’s activities, achievements, and future plans. It is also an excellent way to participate in decision-making relating to the future of FFN. Members’ views and contributions are very much appreciated and we hope you will be able to attend.

Please note that only FFN members can attend the General Assembly. 

Register for the General Assembly
View the agenda of the General Assembly
View the FFN Articles of Association
View the minutes of the 2025 General Assembly

Hip fractures are associated with substantial disability, morbidity, mortality and healthcare costs. Although fracture risk assessment tools such as FRAX and QFracture are available, these commonly require information obtained through patient assessment, including body mass index and lifestyle factors such as smoking and alcohol use. A prediction tool relying exclusively on routinely collected healthcare data could enable automated population screening and identify high-risk individuals before a fracture occurs.

This nationwide Swedish cohort study included 3,542,647 individuals aged ≥50 years who had not been prescribed osteoporosis medication during the previous two years, with a median follow-up of approximately 9 years. During follow-up, 142,327 hip fractures occurred. Using national registry data encompassing diagnoses, prescribed medications, procedures, demographic and socioeconomic information, the researchers developed FRACTURE-ML, a clinical decision support tool for hip fracture prediction. DeepSurv and XGBoost machine-learning models were evaluated alongside traditional Cox regression models.

The DeepSurv-based FRACTURE-ML model demonstrated excellent discrimination, achieving an AUC of 0.89 at one year, with high predictive performance maintained over longer follow-up. A simplified model using only 35 predictors showed similar performance, while traditional Cox models achieved comparable discrimination and calibration.

Compared with an approach using recent fracture as a proxy for FLS-based secondary prevention, FRACTURE-ML identified nearly seven times more individuals at risk of hip fracture within two years, with a reduction in specificity. Importantly, the authors emphasize that the approaches should not be viewed as competing: FRACTURE-ML could complement established FLS programmes by identifying additional individuals for primary prevention, while FLS targets people who have already sustained a fracture.

These findings suggest that automated use of routinely available healthcare data could provide a resource-efficient population screening strategy. Individuals identified as being at elevated risk could subsequently undergo targeted evaluation, including assessment of physical function, balance and bone mineral density, followed by appropriate interventions such as fall prevention and osteoporosis treatment.

However, external validation in other countries and implementation studies are still needed to establish the clinical utility and generalizability of FRACTURE-ML before widespread implementation in routine practice.

Read the article here.

Fragility fractures are a major challenge in aging societies, causing pain, disability, loss of independence, recurrent fractures, and mortality. Although prevention appropriately emphasizes osteoporosis, bone mineral density (BMD), fracture-risk estimation, and treatment, fracture vulnerability is not determined by bone strength alone. Frailty, sarcopenia, impaired balance, falls, malnutrition, cognitive impairment, physiological reserve, and rehabilitation capacity also influence fracture occurrence and recovery. Thus, fragility fracture vulnerability should be considered a multidimensional risk state.

Frailty captures reductions in physiological reserve across mobility, nutrition, cognition, endurance, balance, and resilience. It is associated with falls, fractures, postoperative complications, functional decline, readmission, and mortality after hip fracture. Sarcopenia focuses on muscle strength, quantity or quality, and physical performance. Muscle dysfunction may impair gait stability, balance, protective responses, and impact attenuation during falls, while reduced muscle loading may negatively affect bone health. Sarcopenia can also limit mobility and rehabilitation after fracture. Handgrip strength, chair-stand performance, gait speed, balance testing, and muscle-mass assessment are among the measures used in evaluation.

Osteosarcopenia, the coexistence of osteoporosis or osteopenia and sarcopenia, bridges the skeletal and muscle aspects of fracture risk. However, it does not fully capture broader differences in physiological reserve, resilience, fall vulnerability, and recovery capacity. The proposed bone–muscle–function framework integrates three domains: bone, representing skeletal strength and structural fragility; muscle, representing neuromuscular capacity and physical performance; and function, representing patient-level reserve, mobility, fall vulnerability, rehabilitation participation, and recovery potential. The framework complements rather than replaces osteoporosis-centered care and organizes these domains for risk identification, vulnerability profiling, intervention planning, recovery planning, and secondary prevention.

Clinically, the framework supports multidimensional assessment before and after fracture. Before fracture, evaluation can combine fracture history, BMD or FRAX, muscle strength or performance, fall history, mobility limitations, and frailty screening to identify vulnerabilities. Interventions can then be individualized through osteoporosis treatment, resistance exercise, nutritional support, balance training, fall prevention, mobility support, geriatric assessment, and rehabilitation. After fracture, the framework integrates skeletal treatment with muscle and functional assessment to guide recovery and secondary prevention. Fracture liaison services may provide a practical platform for multidimensional post-fracture assessment, coordinated secondary prevention, and referral to rehabilitation or geriatric services. Future prospective cohort and intervention studies should validate the framework and determine whether vulnerability-based strategies improve skeletal and patient-centered outcomes. 

Read the article here.

Hip fracture remains a major cause of morbidity and mortality among older adults and places a substantial burden on health and social care. Using data from the National Hip Fracture Database (NHFD), a recent study examined 735,436 hip fractures in people between 2011 2023; 71% were women, the mean age was 82.9 years.

The study concludes that although overall hip fracture incidence has fallen, annual numbers continue to rise and patients are increasingly comorbid. The authors call for prevention strategies that include older men, sufficient capacity for increasingly complex perioperative care, and appropriate resources for orthogeriatric multidisciplinary care, discharge planning and community-based intermediate care.

Accompanying editorial

In the accompanying editorial, Prof Antony Johansen describes hip fracture as a useful model for examining wider changes in the care of older people. He notes that modern surgery and anaesthesia are now consistently good and emphasises the importance of multidisciplinary management of frailty. He describes hip fracture and its operative management as a standardised “stress test” of frailty and highlights comprehensive geriatric assessment and orthogeriatrician-led multidisciplinary care as central elements of current hip fracture management.

The editorial also highlights the increasing proportion of men sustaining hip fractures and notes that men are nearly twice as likely to die after a hip fracture, despite NHFD data suggesting that they are more independent, more mobile, better nourished and have better cognition than women. Prof Johansen stresses the need for more detailed assessment to understand these differences. He also discusses the increasing comorbidity of patients while more continue to live in their own homes, and considers the role of shared decision-making and appropriate palliative or non-operative approaches in selected patients. Finally, he cautions that population-level prediction tools may not reliably predict outcomes for an individual patient and should not lead automatically to more conservative treatment decisions.

Read the article here.

Read the editorial here.

Submission Deadline: September 11

Submit your poster here.

Join the FFN

To help make the FFN vision a reality in your country, join the FFN – for free – today
Join FFN Today